Institutional investors hold a majority ownership of ILMN through the 95.81% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2015, these large investors purchased a net $494.5 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LONE PINE CAPITAL LLC Bought 2.9 Million shares of Illumina Inc
THE VANGUARD GROUP, INC. Bought 340.6 Thousand shares of Illumina Inc
ALLIANCEBERNSTEIN LP Bought 326.4 Thousand shares of Illumina Inc